SOURCE: marcus evans

marcus evans

August 04, 2015 11:28 ET

Guarantee Drug Safety With the Right 3rd Party Partners

Interview With Lillian Kirk, DC, Associate Director, Drug Safety Surveillance & Pharmacovigilance, Progenics Pharmaceuticals, Inc.

PHILADELPHIA, PA--(Marketwired - August 04, 2015) - Increased public scrutiny has been driving the focus on drug safety surveillance. Pharmaceutical and Biopharmaceutical professionals continue to face the ongoing pressures from government entities and public concern. With the utmost importance on patient safety and regulatory compliance, pharmaceutical firms must effectively monitor and detect adverse event reports and comply with all regulatory standards.

Lillian, Associate Director, Drug Safety Surveillance & Pharmacovigilance at Progenics Pharmaceuticals, Inc., recently spoke with marcus evans about how she will cover good vendor management practices at the upcoming 5th Pharmacovigilance, Risk Management & AER Conference, September 16-17, 2015 at the Hyatt at the Bellevue in Philadelphia, PA.

What are the positive effects that outsourcing can bring to a company in regards to their drug safety strategy?

LK: Outsourcing specific operations for Drug Safety can allow a small company to leverage the additional safety expertise and experience of a vendor. The vendor's staff can complement the resources that are otherwise not available with a partner. This can be a great help in ensuring that all Safety requirements are met.

How do you determine whether employing a third party vendor is the right move for the company?

LK: A small company sometimes needs to employ a third party vendor when their internal resources are limited. This can be based on necessity.

What factors are assessed when identifying 3rd party partners?

LK: Important factors include expertise, high standards, quality and a good reputation. Their wide range of experience should include capabilities for immediate needs and potential needs for the future.

What do you expect to gain from attending the upcoming meeting in Philadelphia?

LK: I expect to gain and share insights with colleagues in the pharmacovigilance arena. I am hoping to hear informative presentations on what is new in drug safety as well as insights on best practices that have worked for others. I am also hoping to network a little more closely with pharmacovigilance peers to discuss PV issues, triumphs and strategies for success.

Dr. Lillian Kirk, an Associate Director Drug Safety & Pharmacovigilance at Progenics Pharmaceuticals, provides oversight and management of all Drug Safety functions. Lillian is a Doctor of Chiropractic with an extensive healthcare career reflecting 19 years' experience, including clinical practice, college-level teaching, drug safety/pharmacovigilance and medical affairs. She is skilled in a variety of areas of drug safety in both clinical development and post approval/authorization products.

For the last two years, Lillian has been the exclusive drug safety professional onsite and provides safety expertise throughout the company and to all external partners and vendors. She has developed a number of key process improvements including establishing electronic case reporting, generating efficient serious adverse event query processes, creating a medical inquiry database, streamlining information transfer, and literature review tracking.

Organizations that Dr. Kirk has worked at include Pfizer, Purdue Pharma and Bayer HealthCare in a variety of therapeutic areas including oncology, neurology, musculoskeletal, OTC and dietary supplements. She received her DC degree from New York Chiropractic College. She is a member of the Drug Information Association (DIA) and American Medical Writers Association (AMWA).

For the last 4 years, pharmaceutical and biopharmaceutical professionals have left this meeting with the ability to effectively monitor adverse event reports and comply with regulatory standards. This marcus evans conference provides attendees with solutions to the ongoing pressures from government entities and public concern.

Join Lillian at the 5th Pharmacovigilance, Risk Management & AER Conference, September 16-17, 2015 in Philadelphia, PA. For more information, please check out the conference agenda or contact Tyler Kelch, Assistant Marketing Manager for Media/PR, marcus evans at Tylerke@marcusevansch.com.

About marcus evans

Marcus evans conferences annually produce over 2,000 high quality events designed to provide key strategic business information, best practice and networking opportunities for senior industry decision- makers. Our global reach is utilized to attract over 30,000 speakers annually; ensuring niche focused subject matter presented directly by practitioners and a diversity of information to assist our clients in adopting best practice in all business disciplines.

Image Available: http://www.marketwire.com/library/MwGo/2015/8/4/11G049622/Images/LK_image-413491652013.jpg

Contact Information